Imvax Company
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Industry:
Whole-Cell Antigens
Funding Status:
Late Stage Venture
Estimated Revenue:
Less than $1M
Investors Number:
6
Headquarters:
Philadelphia, Pennsylvania, United States
Employee Number:
11-50
Total Funding:
166694660
Founded Date:
2015-01-01
Last Funding Type:
Series C
Last Funding Date:
2020-07-16